Result of AGM

RNS Number : 5737R

Assura PLC

06 July 2022

 

6 July 2022

Assura plc ("Company")

Result of AGM

Assura plc announces that at its Annual General Meeting held earlier today, each of the resolutions submitted to the meeting (as set out in the Notice of the Meeting dated 1 June 2022) were passed by the requisite majorities on a poll.

Resolution	For	% For	Against	% Against	Total Votes Cast (% of issued share capital)	Votes Withheld
1. To receive the Company's report and accounts	2,536,398,504	99.25	19,045,186	0.75	2,555,443,690 (86.43)	4,911,379
2. To approve the Directors' Remuneration Policy	2,512,011,438	98.11	48,281,965	1.89	2,560,293,403 (86.60)	61,666
3. To approve the Directors' Remuneration Report	2,522,696,378	98.53	37,581,807	1.47	2,560,278,185 (86.60)	76,884
4. To re-appoint Ernst & Young LLP as auditor of the Company	2,511,745,712	98.10	48,594,581	1.90	2,560,340,293 (86.60)	14,776
5. To authorise the Audit Committee to determine the auditor's remuneration	2,526,741,114	98.69	33,558,682	1.31	2,560,299,796 (86.60)	55,273
6. To re-elect Ed Smith as a Director of the Company	2,474,673,155	96.65	85,649,713	3.35	2,560,322,868 (86.60)	32,201
7. To re-elect Louise Fowler as a Director of the Company	2,544,566,232	99.38	15,759,757	0.62	2,560,325,989 (86.60)	29,080
8. To re-elect Jonathan Murphy as a Director of the Company	2,540,837,168	99.24	19,488,821	0.76	2,560,325,989 (86.60)	29,080
9. To re-elect Jayne Cottam as a Director of the Company	2,532,695,523	98.92	27,629,552	1.08	2,560,325,075 (86.60)	29,994
10. To re-elect Jonathan Davies as a Director of the Company	2,545,589,609	99.42	14,736,380	0.58	2,560,325,989 (86.60)	29,080
11. To re-elect Sam Barrell as a Director of the Company	2,545,932,676	99.44	14,392,399	0.56	2,560,325,075 (86.60)	29,994
12. To re-elect Emma Cariaga as a Director of the Company	2,559,436,807	99.97	888,268	0.03	2,560,325,075 (86.60)	29,994
13. To re-elect Noel Gordon as a Director of the Company	2,559,293,587	99.96	1,031,488	0.04	2,560,325,075 (86.60)	29,994
14. To authorise the Directors to allot shares	2,445,882,244	95.57	113,460,633	4.43	2,559,342,877 (86.56)	1,012,192
15. To empower the Directors to disapply pre-emption rights	2,554,885,524	99.99	239,721	0.01	2,555,125,245 (86.42)	5,229,824
16. To empower the Directors to disapply pre-emption rights in connection with an acquisition or specified capital investment	2,526,205,951	98.87	28,924,336	1.13	2,555,130,287 (86.42)	5,224,782
17. To authorise the market purchase of the Company's own shares	2,556,408,332	99.97	675,960	0.03	2,557,084,292 (86.49)	3,270,777
18. To authorise the Company to call any general meeting, other than the Annual General Meeting, by not less than 14 clear days' notice	2,402,436,333	93.83	157,906,184	6.17	2,560,342,517 (86.60)	12,552

Resolutions 1-14 were passed as ordinary resolutions. Resolutions 15-18 were passed as special resolutions. Votes 'For' include votes at the discretion of the Chairman. 

Notes:

1. The percentages above are rounded to two decimal places.

2. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "for" and "against" a resolution.

3. The number of ordinary shares in issue on the share register at 6.00pm on 5 July 2022 was 2,956,564,843 of which the Total Voting Rights figure was 2,956,564,843.

Copies of resolutions 15-18, being resolutions other than resolutions concerning ordinary business passed by the Company at the above AGM, have been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

- Ends -

For more information, please contact:

Assura plc	Tel: [phone]
Orla Ball, Company Secretary David Purcell, Investor Relations Director	Email: [e-mail]
FGS Global Gordon Simpson James Thompson	Tel: [phone] Email: [e-mail]

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Warrington, UK - caring for more than 600 primary healthcare buildings, from which almost seven million patients are served.

A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2022, Assura's portfolio was valued at £2,752 million.

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. 

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

* EPRA is a registered trademark of the European Public Real Estate Association
Assura plc LEI code: 21380026T19N2Y52XF72

 

END

 

 

RAGSSFFLMEESEDW